Oseltamivir

CHEMBL1229 Phase 4 अनुमोदित Small molecule

Half-Life

6-10 hours

Bioavailability

—

Protein Binding

—

Molecular Weight

312.4 g/mol

LogP

1.1

Phase

4

A neuraminidase inhibitor, oseltamivir treats and prevents influenza by blocking the enzyme that newly formed viral particles use to detach from infected cells, limiting the virus's spread through the respiratory tract. Marketed as Tamiflu, it has the formula C16H28N2O4 and is most effective when started within 48 hours of symptom onset.

An antiviral neuraminidase inhibitor for treating and preventing influenza, most effective within 48 hours.

आणविक भार

312.4050 g/mol

LogP

1.10

TPSA

90.70 Å²

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

संक्रामक रोग

दवा वर्ग

J — J - प्रणालीगत उपयोग हेतु एंटीइन्फेक्टिव

क्रिया का तंत्र

Neuraminidase inhibitor preventing viral release from host cells.

Pharmacokinetics (PK)

Half-Life 6-10 hours

Pharmacodynamics (PD)

तंत्र

Neuraminidase inhibitor preventing viral release from host cells.

2D संरचना

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1

InChI

InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1

Molecular Formula

C16H28N2O4

HBD / HBA

2 / 5

घूर्णनीय बंधन

8

भारी परमाणु

22

No targets recorded

Target interaction data is not yet available for this drug.

Minor Oseltamivir + Warfarin

Oseltamivir does not appear to meaningfully alter warfarin pharmacokinetics; however, the febrile illness being treated may independently elevate INR, which can be mistakenly attributed to the antiviral.

Minor Oseltamivir + Methotrexate

Both oseltamivir carboxylate and methotrexate rely on renal tubular secretion via OAT transporters; theoretically, competition could reduce elimination of either drug, though clinical evidence of a significant interaction is limited.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

An antiviral neuraminidase inhibitor for treating and preventing influenza, most effective within 48 hours.

Neuraminidase inhibitor preventing viral release from host cells.

Key pharmacokinetic parameters for Oseltamivir: Half-life: 6-10 hours.

Yes, Oseltamivir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

ADME Journey →

Related Drugs

Same Drug Class

Amoxicillin Small molecule Azithromycin Small molecule Ciprofloxacin Small molecule Doxycycline Small molecule

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1229. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 65028. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

रोगी-अनुकूल जानकारी खोज रहे हैं?

Oseltamivir PillFYI पर

संरचना

त्वरित डेटा

Class: J - प्रणालीगत उपयोग हेतु एंटीइन्फेक्टिव
सूत्र: C16H28N2O4
पर्यायवाची: 2

बाहरी लिंक

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

Oseltamivir

चिकित्सीय क्षेत्र

दवा वर्ग

क्रिया का तंत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

Cite this structure

Embed this structure

No targets recorded

No side effects recorded

अक्सर पूछे जाने वाले प्रश्न

Related Drugs

Same Drug Class

References & Data Sources

Embed This Widget